All Industries

Top Therapeutics Companies

765 Therapeutics companies, sorted by total funding raised.

GalectoIPO

Clinical-stage biotech developing small-molecule therapeutics targeting galectin and other mechan...

Copenhagen, Denmark11–50Biotech, Drug Discovery
Series CTotal funding$446.9MNov 2025
X4 PharmaceuticalsIPO

Clinical-stage biopharmaceutical company developing novel, oral medicines designed to treat a ran...

Boston, United States51–200Biotech, Drug Discovery
Series CTotal funding$446.8MOct 2025
Verve TherapeuticsAcquired

Verve Therapeutics develops gene-editing treatments for atherosclerotic cardiovascular disease us...

Boston, United States201–500Biotech, Drug Discovery
Series CTotal funding$428.5MOct 2024
Areteia TherapeuticsClosed

Clinical-stage biotechnology company formerly based in Chapel Hill that is no longer operating an...

Chapel Hill, United States11–50Biotech, Life Sciences
Series ATotal funding$425.0MFeb 2024
Verdiva Bio

Verdiva Bio is a clinical-stage biopharmaceutical company focused on developing innovative therap...

London, United Kingdom11–50Life Sciences, Biotech
Series ATotal funding$411.0MJan 2025
Sonoma Biotherapeutics

Develops engineered regulatory T cell therapies to restore immune balance and treat autoimmune an...

Seattle, United States51–200Biotech, Life Sciences
Corporate RoundTotal funding$410.0MSep 2024
ArcellxAcquired

Arcellx is a clinical-stage biopharmaceutical company developing novel, adaptive and controllable...

Redwood City, United States51–200Biotech, Healthcare
SeedTotal funding$375.0MJan 2024
AvalynIPO

Avalyn Pharma develops inhaled formulations of approved medicines to improve treatment benefits a...

Boston, United States11–50Biotech, Healthcare
Series DTotal funding$372.5MJul 2025
Alentis Therapeutics

Alentis Therapeutics develops anti-Claudin-1 antibodies and antibody-drug conjugates for Claudin-...

Basel, Switzerland51–200Biotech, Drug Discovery
Series DTotal funding$365.9MNov 2024
Oricell Therapeutics

Oricell develops next-generation cell therapies addressing unmet needs in oncology and immunology...

Shanghai, China51–200Oncology, Therapeutics
Venture RoundTotal funding$364.0MApr 2026
Umoja

Develops in vivo CAR T cell therapies that generate CAR T cells inside patients to treat cancer.

Seattle, United States201–500Biotech, Drug Discovery
Series CTotal funding$363.0MJan 2025
Ventus Therapeutics

Clinical-stage biopharmaceutical company using structural biology and computational chemistry to ...

Montreal, Canada11–50Biotech, Drug Discovery
GrantTotal funding$360.1MApr 2023
PIONYR ImmunotherapeuticsAcquired

Pionyr Immunotherapeutics is developing cancer immunotherapies that target the tumor microenviron...

South San Francisco, United States51–200Biotech, Healthcare
Corporate RoundTotal funding$355.0MJun 2020
Aspen Neuroscience

Biotech company developing the first autologous iPSC-derived neuron replacement cell therapy for ...

San Diego, United States51–200Biotech, Healthcare
Series CTotal funding$339.0MNov 2025
Solve Therapeutics

Solve Therapeutics is a biopharmaceutical company that develops next-gen antibody-drug conjugates...

Belmont, United States11–50Life Sciences, Biotech
Series BTotal funding$321.0MNov 2025
Bicara TherapeuticsIPO

Clinical-stage biopharma developing dual-action biologics that combine targeted therapy and immun...

Cambridge, United States51–200Biotech, Healthcare
Series CTotal funding$313.0MDec 2023
Arbor Biotechnologies

Develops next-generation gene editing therapeutics for genetic diseases, advancing liver and CNS ...

Cambridge, United States51–200Biotech, Drug Discovery
Series CTotal funding$304.5MMar 2025
ErytechClosed

A clinical-stage biopharma company based in Lyon, France

Lyon, France51–200Biotech, Therapeutics
Private EquityTotal funding$274.6MNov 2017
FibroGenIPO

Develops novel therapeutics in oncology and anemia, advancing antibody-drug conjugates and HIF-PH...

San Francisco, United States11–50Biotech, Life Sciences
Venture RoundTotal funding$261.5MNov 2022
Apollo Therapeutics

Biopharmaceutical company advancing therapeutic programs

Biotech, Healthcare
Extension RoundTotal funding$260.0MJan 2024
Myeloid Therapeutics

Clinical-stage biotech pioneering in vivo multi-immune programming using proprietary mRNA-LNP CAR...

Cambridge, United States11–50Biotech, Therapeutics
Series BTotal funding$257.0MMay 2026
Seismic Therapeutic

Clinical-stage immunology biotech using machine learning to design biologic therapeutics for auto...

Cambridge, United States51–200Biotech, Drug Discovery
Extension RoundTotal funding$247.0MJul 2025
Agios PharmaceuticalsIPO

Agios develops medicines for rare diseases by applying cellular-metabolism science, with programs...

Cambridge, United States501–1000Biotech, Drug Discovery
Series CTotal funding$241.0MNov 2011
Ray Therapeutics

Ray Therapeutics develops optogenetic gene therapies designed to restore vision for people with d...

Berkeley, United States11–50Biotech, Genomics
Series BTotal funding$241.0MApr 2026
Engrail Therapeutics

Engrail Therapeutics is a clinical-stage pharmaceutical company developing precision-targeted the...

San Diego, United States11–50Biotech, Drug Discovery
Series BTotal funding$221.0MMar 2024